Cimetidine (Cymi, A-lennon Cimetidine, Lenamet Otc, Ulcim, Tagamet, Tagamet Iv, Lenamet, Dyspamet Chewtab, Dyspamet, Lenamet 2oo Mg/)
Cimetidine
Pharmacare limited û woodmead
Registration
- Applicant
- Pharmacare limited û woodmead
- Registrations
- 17
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cymi - 200 EACH TABLET CONTAINS CIMETIDINE 200 MG | - 200 | 28018828/11.4.3/0188 | Cancelled | Not determined | None |
| A-lennon cimetidine 400 MG tablets EACH TABLET CONTAINS CIMETIDINE 400 MG | 400 mgTablets | 28018928/11.4.3/0189 | Cancelled | Not determined | None |
| Lenamet otc EACH TABLET CONTAINS CIMETIDINE 200 mg | Not listed | 30041230/11.4.3/0412 | Registered | Not determined | None |
| Ulcim injection EACH 2 ml SOLUTION CONTAINS CIMETIDINE 200 mg | Injection | 30049230/11.4.3/0492 | Cancelled | Not determined | None |
| Tagamet 200 EACH TABLET CONTAINS CIMETIDINE 200 mg | 200 | J0307J/11.4.3/307 | Cancelled | Not determined | None |
| Tagamet syrup 200 mg/5 ML EACH 5 mL SYRUP CONTAINS CIMETIDINE HYDROCHLORIDE EQUIVALENT TO CIMETIDINE 200 mg | 200 mg/5 mlSyrup | J0308J/11.4.3/308 | Cancelled | Not determined | None |
| Tagamet ampoules 200 MG EACH 2 ml SOLUTION CONTAINS CIMETIDINE 200 mg | 200 mgAmpoules | J0309J/11.4.3/309 | Cancelled | Not determined | None |
| Tagamet tablets 400 MG EACH TABLET CONTAINS CIMETIDINE 400 mg | 400 mgTablets | P0173P/11.4.3/173 | Cancelled | Not determined | None |
| Tagamet iv 400 EACH 100,0 ml SOLUTION CONTAINS CIMETIDINE 400,0mg | 400 | S0328S/11.4.3/328 | Cancelled | Not determined | None |
| Tagamet tablets 800 MG EACH TABLET CONTAINS CIMETIDINE 800,0 mg | 800 mgTablets | T0022T/11.4.3/22 | Cancelled | Not determined | None |
| Lenamet 200 EACH TABLET CONTAINS CIMETIDINE 200 MG | 200 | U0066U/11.4.3/66 | Cancelled | Not determined | None |
| Lenamet-400 EACH TABLET CONTAINS CIMETIDINE 400 MG | 400 | U0067U/11.4.3/67 | Cancelled | Not determined | None |
| Lenamet - 800 EACH TABLET CONTAINS CIMETIDINE 800 mg | - 800 | W0227W/11.4.3/227 | Cancelled | Not determined | None |
| Dyspamet chewtab tablets 200 MG EACH TABLET CONTAINS CIMETIDINE 200 mg | 200 mgTablets | W0307W/11.4.3/307 | Cancelled | Not determined | None |
| Dyspamet suspension 200 mg/5 ML EACH 5 ml SUSPENSION CONTAINS CIMETIDINE 200 mg | 200 mg/5 mlSuspension | W0308W/11.4.3/308 | Cancelled | Not determined | None |
| Lenamet injection 2oo mg/2 ML EACH 2 ml AMPOULE CONTAINS CIMETIDINE 200 mg | 2 mlInjection | Y0032Y/11.4.3/32 | Registered | Not determined | None |
| Ulcim 200 MG EACH TABLET CONTAINS CIMETIDINE 200 mg | 200 mg | Z0176Z/11.4.3/176 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Cimetidine
- except when intended for the short-term symptomatic relief of heartburn, dyspepsia and hyperacidity, subject to a maximum unit dose of 200 milligrams, a maximum daily dose (per 24 hours) of 800 milligrams and a maximum treatment period of 2 weeks. (S2)
Consolidated Schedules 06 July 2026, lines 3332 to 3334
S2: Cimetidine
- when intended for the short-term symptomatic relief of heartburn, dyspepsia and hyperacidity, subject to a maximum unit dose of 200 milligrams, a maximum daily dose of 800 milligrams and a maximum treatment period of 2 weeks. (S3)
Consolidated Schedules 06 July 2026, lines 1740 to 1742
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
1-Cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine
Drag to rotate. Structure from PubChem CID 2756.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.